OVERVIEW
The market size for precision medicine software is expected to reach USD 2.04 billion by 2024, rising at a CAGR of 11.45% during the forecast period. Factors such as increasing government funding for precision medicine programs, collaborations between pharmaceutical and software companies, and growth in the number of patients with cancer are driving growth in the software market for precision medicine.
TABLE OF CONTENT
1 Global Precision Medicine Software Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Precision Medicine Software Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Precision Medicine Software Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Precision Medicine Software Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Precision Medicine Software Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Precision Medicine Software Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Precision Medicine Software Market – By Delivery Mode (Market Size – &
million/billion)
8.1 On-premise Delivery Mode
8.2 Cloud-based Delivery Mode
9 Global Precision Medicine Software Market – By Application
9.1 Oncology
9.2 Pharmacogenomics
9.3 Rare Diseases
9.4 Other
10 Global Precision Medicine Software Market – By End-User
10.1 Healthcare Providers
10.2 Research Centers and Academic Institutes
10.3 Pharmaceutical and Biotechnology Companies
10.4 Other
11 Global Precision Medicine Software Market – By Geography (Market Size – &
million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Precision Medicine Software Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Precision Medicine Software Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Syapse, Inc.
13.3 2bprecise, LLC
13.4 Fabric Genomics, Inc.
13.5 Pieriandx, Inc.
13.6 Foundation Medicine, Inc.
13.7 Translational Software Inc.
13.8 Sunquest Information Systems, Inc.
13.9 Sophia Genetics Sa
13.10 N-Of-One, Inc. (A Subsidiary of Qiagen N.V.)
13.11 Human Longevity, Inc.
13.12 Company 11 & more
14 Global Precision Medicine Software Market – Appendix
14.1 Sources
14.2 Abbreviations